The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
SOCIETY: AGA This session is focused on novel strategies for developing microbiome therapeutics including the use of synthetic communities, editing microbial communities using tools such as CRISPR and the use of phages as therapeutic tools.
SOCIETY: AGA This session will feature cutting-edge research on the multifaceted aspects of Clostridioides difficile colitis, presenting the latest findings in pathogenesis and innovative therapeutic approaches. Attendees will gain valuable insights into the molecular and immunological aspects of C…